We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00714077
Recruitment Status : Recruiting
First Posted : July 14, 2008
Last Update Posted : February 17, 2016
Sponsor:
Collaborators:
Zhejiang Cancer Hospital
Cancer Hospital of Guizhou Province
Shandong Cancer Hospital and Institute
Hebei Medical University Fourth Hospital
Peking University Third Hospital
General Hospital of Chinese Armed Police Forces
Beijing Hospital
Information provided by (Responsible Party):
Jing Jin, M.D., Chinese Academy of Medical Sciences

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : January 2018
  Estimated Study Completion Date : June 2018